ACM
TMDX icon

Aquatic Capital Management’s Transmedics TMDX Stock Holding History

Aquatic Capital Management’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-33,290
Closed -$2.24M – 1540
2025
Q1 		$2.24M Sell
33,290
-9,859
-23% -$678K 0.06% 391
2024
Q4 		$2.69M Buy
43,149
+2,149
+5% +$200K 0.07% 316
2024
Q3 		$6.44M Buy
41,000
+25,200
+159% +$3.88M 0.17% 154
2024
Q2 		$2.38M Buy
+15,800
New +$1.9M 0.09% 235
2024
Q1 		– Sell
-1,400
Closed -$111K – 1641
2023
Q4 		$111K Sell
1,400
-27,200
-95% -$1.64M ﹤0.01% 987
2023
Q3 		$1.57M Buy
+28,600
New +$2.06M 0.07% 267
2022
Q4 		– Sell
-500
Closed -$21K – 1824
2022
Q3 		$21K Buy
+500
New +$21.7K ﹤0.01% 994
2022
Q1 		– Sell
-900
Closed -$17K – 1525
2021
Q4 		$17K Buy
+900
New +$22.6K 0.03% 650

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Aquatic Capital Management's TMDX Position: Q2 2025 in Review

Aquatic Capital Management sold out of Transmedics (TMDX) in Q2 2025, closing a stake of 33,290 shares — an estimated $2.24M sold.

Aquatic Capital Management first reported a position in TMDX in Q4 2021 and held it in 8 quarters. The position peaked at $6.44M in Q3 2024. 368 funds tracked by Wall St. Rank hold TMDX as of Q2 2025.

  • Aquatic Capital Management reported no remaining Transmedics position as of Q2 2025 after selling out during the quarter.
  • Aquatic Capital Management sold 33,290 Transmedics shares in Q2 2025, an estimated $2.24M.
  • Aquatic Capital Management first reported a position in Transmedics in Q4 2021 and held it in 8 quarters.
  • Aquatic Capital Management's Transmedics position peaked at $6.44M in Q3 2024.
  • 368 funds tracked by Wall St. Rank held Transmedics as of Q2 2025.

Based on Aquatic Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.